<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04234126</url>
  </required_header>
  <id_info>
    <org_study_id>Gallbladder status and PEC</org_study_id>
    <nct_id>NCT04234126</nct_id>
  </id_info>
  <brief_title>The Relationship Between Post-ERCP-choledocholithiasis and Gallbladder Status</brief_title>
  <official_title>Does the Gallbladder Status Influence the Occurence of Post-Endoscopic Retrograde Choledochopancreatography(ERCP) -Choledocholithiasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hepatopancreatobiliary Surgery Institute of Gansu Province</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hepatopancreatobiliary Surgery Institute of Gansu Province</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this retrospective study, the investigators evaluate the relationship of
      post-ERCP-choledocholithiasis(PEC ) and the gallbladder status as a risk factor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When patients have common bile duct(CBD) stones, ERCP is widely used for stone extraction
      instead of clinical operation. ERCP has many advantages like less injury or faster recovery.
      However, according to literature, ERCP will has a mostly 10% possibility to get an acute
      purulent cholecystitis, which often requires emergency intervention, therefore, it is
      necessary to know if the gallbladder status(chronic disease) is one of the important risk
      factors of PEC like the gallbladder wall thickness, chronic cholecystitis, polyps,crudely or
      calculus.

      .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Acute PEC(post-ERCP-cholecystitis )</measure>
    <time_frame>1 month</time_frame>
    <description>When the PEC occurs, the temperature should be more than 38 celsius degree, right upper abdominal pain, the total amount of the White Blood Cell (WBC) is above normal for the patients who with the gallbladder wall thickness under ultrasound examination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Pancreatitis</measure>
    <time_frame>1 month</time_frame>
    <description>Typical abdominal pain, with the level of serum amylase increasing at least 3 times of the normal range within 24 hours after ERCP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Cholangitis</measure>
    <time_frame>1 month</time_frame>
    <description>Temperature should be more than 38 celsius degree, chills, with right upper abdominal pain, blood routine showing the total amount of the White Blood Cell (WBC), and the amount of polymorphonuclear neutrophil(PMN) are above normal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Perforation</measure>
    <time_frame>1 month</time_frame>
    <description>Typical abdominal pain,abdominal muscle tension, and there are also radiographic evidence suggesting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with bile duct stents</measure>
    <time_frame>1 month</time_frame>
    <description>If it is necessary to get the patients drainage, Number of Participants with stents or endoscopic nasobiliary drainage (ENBD) should be recorded</description>
  </secondary_outcome>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Cholecystitis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERCP</intervention_name>
    <description>Routine ERCP for CBD stone with the gallbladder in situ, the chronic gallbladder status was defined as gallbladder wall thickness≥4mm, chronic cholecystitis, polyps,crudely or calculus .</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Routine ERCP patients with CBD stones
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Routine ERCP for CBD stone patients with gallbladder in situ

        Exclusion Criteria:

          -  Unwillingness or inability to consent for the study

          -  Unstable vital signs Coagulation dysfunction (INR&gt;1.5) and low peripheral blood
             platelet count (&lt;50×10 ^9 / L) or using anti-coagulation drugs

          -  Any Prior surgery for CBD including ERCP

          -  Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe
             liver disease (such as decompensated liver cirrhosis, liver failure and so on), septic
             shock

          -  Biliary- duodenal fistula confirmed during ERCP

          -  Pregnant women or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenbo Meng, M.D., Ph. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hepatopancreatobiliary Surgery Institute of Gansu Province</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenbo Meng, M.D., Ph. D.</last_name>
    <phone>+8613919177177</phone>
    <email>mengwb@lzu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xu Zhang, M.D.</last_name>
    <phone>+8613919497484</phone>
    <email>xzhang@lzu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hepatopancreatobiliary Surgery Institute of Gansu Province</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>730000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenbo Meng, MD,PhD</last_name>
      <phone>+8613919177177</phone>
      <email>mengwb@lzu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Wenbo Meng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Cao J, Ding X, Wu H, Shen Y, Zheng R, Peng C, Wang L, Zou X. Classification of the cystic duct patterns and endoscopic transpapillary cannulation of the gallbladder to prevent post-ERCP cholecystitis. BMC Gastroenterol. 2019 Aug 5;19(1):139. doi: 10.1186/s12876-019-1053-6.</citation>
    <PMID>31382888</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>March 29, 2020</last_update_submitted>
  <last_update_submitted_qc>March 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hepatopancreatobiliary Surgery Institute of Gansu Province</investigator_affiliation>
    <investigator_full_name>Wenbo Meng</investigator_full_name>
    <investigator_title>M.D., Ph. D, Director of surgery</investigator_title>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>Acute purulent cholecystitis</keyword>
  <keyword>Bile duct stone</keyword>
  <keyword>PEC(post-ERCP-choledocholithiasis)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Choledocholithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

